THE SAME MUTATION THAT ENCODES LOW-LEVEL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE TO 2',3'-DIDEOXYINOSINE AND 2',3'-DIDEOXYCYTIDINE CONFERS HIGH-LEVEL RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE

被引：227
|
作者：
GAO, Q
GU, ZX
PARNIAK, MA
CAMERON, J
CAMMACK, N
BOUCHER, C
WAINBERG, MA
机构：
[1] SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST,3755 CHEMIN COTE ST CATHERINE,MONTREAL H3T 1E2,QUEBEC,CANADA
[2] MCGILL UNIV,AIDS CTR,MONTREAL H3A 2T5,QUEBEC,CANADA
[3] GLAXO GRP RES LTD,GREENFORD UB6 0HE,MIDDX,ENGLAND
[4] UNIV AMSTERDAM,ACAD MED CTR,DEPT MED MICROBIOL,1105 AZ AMSTERDAM,NETHERLANDS
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1993年 / 37卷 / 06期
关键词：
D O I：
10.1128/AAC.37.6.1390
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Variants of human immunodeficiency virus type 1 that display 500- to 1,000-fold resistance to the (-) enantiomer of 2'-deoxy-3'-thiacytidine and almost-equal-to 4- to 8-fold resistance to 2',3'-dideoxycytidine and 2',3'-dideoxyinosine have been generated through in vitro selection with the former compound. The polymerase regions of several of these resistant viruses shared a codon alteration at site 184 (ATG --> GTG; methionine --> valine), a mutation previously associated with low-level resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine. The biological relevance of this mutation for the (-) enantiomer of 2'-deoxy-3'-thiacytidine was confirmed by site-directed mutagenesis with the HXB2-D clone of human immunodeficiency virus type 1.
引用
收藏
页码：1390 / 1392
页数：3
相关论文
共 50 条
  • [41] EVALUATION OF SYNERGY BETWEEN CARBOVIR AND 3'-AZIDO-2',3'-DEOXYTHYMIDINE FOR INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMITH, MS
    KESSLER, JA
    RANKIN, CD
    PAGANO, JS
    KURTZBERG, J
    CARTER, SG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) : 144 - 147
  • [42] Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy
    Larder, BA
    Kohli, A
    Bloor, S
    Kemp, SD
    Harrigan, PR
    Schooley, RT
    Lange, JMA
    Pennington, KN
    StClair, MH
    JOURNAL OF VIROLOGY, 1996, 70 (09) : 5922 - 5929
  • [43] MECHANISM OF THE POTENTIATING EFFECT OF RIBAVIRIN ON THE ACTIVITY OF 2',3'-DIDEOXYINOSINE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS
    BALZARINI, J
    LEE, CK
    HERDEWIJN, P
    DECLERCQ, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (32) : 21509 - 21514
  • [44] Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)β-L-2′,3′-dideoxy-3′-thiacytidine
    King, RW
    Ladner, SK
    Miller, TJ
    Zaifert, K
    Perni, RB
    Conway, SC
    Otto, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3179 - 3186
  • [45] Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109
    Balzarini, J
    Wedgwood, O
    Kruining, J
    Pelemans, H
    Heijtink, R
    DeClercq, E
    McGuigan, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (02) : 363 - 369
  • [46] CELLULAR-METABOLISM OF 2',3'-DIDEOXYCYTIDINE, A COMPOUND ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS INVITRO
    STARNES, MC
    CHENG, YC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (03) : 988 - 991
  • [47] RAPID INVITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-THIACYTIDINE INHIBITORS DUE TO A MUTATION IN THE YMDD REGION OF REVERSE-TRANSCRIPTASE
    TISDALE, M
    KEMP, SD
    PARRY, NR
    LARDER, BA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5653 - 5656
  • [48] ENANTIOMERIC 2',3'-DIDEOXYCYTIDINE DERIVATIVES ARE POTENT HUMAN-IMMUNODEFICIENCY-VIRUS INHIBITORS IN CELL-CULTURES
    GOSSELIN, G
    MATHE, C
    BERGOGNE, MC
    AUBERTIN, AM
    KIRN, A
    SCHINAZI, RF
    SOMMADOSSI, JP
    IMBACH, JL
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1994, 317 (01): : 85 - 89
  • [49] SYNERGISTIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION INVITRO BY 2-DRUG AND 3-DRUG COMBINATIONS OF 3'-AZIDO-3'-DEOXYTHYMIDINE, PHOSPHONOFORMATE, AND 2',3'-DIDEOXYTHYMIDINE
    KONG, XB
    ZHU, QY
    RUPRECHT, RM
    WATANABE, KA
    ZEIDLER, JM
    GOLD, JWM
    POLSKY, B
    ARMSTRONG, D
    CHOU, TC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) : 2003 - 2011
  • [50] In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2′,3′-dideoxy-3′-fluoroguanosine
    Jacquard, AC
    Brunelle, MN
    Pichoud, C
    Durantel, D
    Carrouée-Durantel, S
    Trepo, C
    Zoulim, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 955 - 961
12345